Concentrix (NASDAQ: CNXC) insider transactions
In the twelve months to 10 November 2026, executives and directors of Concentrix reported 2 open-market sales of 6,000,500 shares ($133.5m) and 4 open-market purchases of 5,500 shares ($155,165), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 27 October 2026 | Gibson Craig | EVP, Global Sales, Acct Mgmt | Shares withheld for tax | −1,403 | $31.02 | 52,196 | Form 4 |
| 8 July 2026 | Caldwell Christopher A | President and CEO | Open-market purchase | +1,000 | $21.25 | 358,382 | Form 4 |
| 29 April 2026 | GBL Verwaltung S.A. | — | Open-market sale | −6,000,000 | $22.25 | 2,773,667 | Form 4 |
| 9 April 2026 | Valentine Andre S | Chief Financial Officer | Open-market purchase | +2,500 | $27.95 | 89,066 | Form 4 |
| 26 March 2026 | Caldwell Christopher A | President and CEO | Open-market purchase | +1,000 | $26.97 | 357,382 | Form 4 |
| 25 March 2026 | Vezina Ann F | Director | Grant or award | +7,701 | — | 19,648 | Form 4 |
| 25 March 2026 | Polk Dennis | Director | Grant or award | +7,701 | — | 28,924 | Form 4 |
| 25 March 2026 | Marinello Kathryn V | Director | Grant or award | +7,701 | — | 17,704 | Form 4 |
| 25 March 2026 | Hayley Kathryn | Director | Grant or award | +7,701 | — | 17,712 | Form 4 |
| 25 March 2026 | Deason Jennifer | Director | Grant or award | +7,701 | — | 17,704 | Form 4 |
| 25 March 2026 | Ogut Bilge | Director | Grant or award | +7,701 | — | 7,701 | Form 4 |
| 25 March 2026 | Cheng Chih-Kai | Director | Grant or award | +7,701 | — | 7,701 | Form 4 |
| 25 March 2026 | Council LaVerne H | Director | Grant or award | +7,701 | — | 17,704 | Form 4 |
| 1 February 2026 | Fogarty Jane | EVP, Legal | Shares withheld for tax | −563 | $37.35 | 31,030 | Form 4 |
| 1 February 2026 | Gibson Craig | EVP, Global Sales, Acct Mgmt | Shares withheld for tax | −799 | $37.35 | 53,599 | Form 4 |
| 1 February 2026 | Valentine Andre S | Chief Financial Officer | Shares withheld for tax | −864 | $37.35 | 86,566 | Form 4 |
| 1 February 2026 | Caldwell Christopher A | President and CEO | Shares withheld for tax | −5,693 | $37.35 | 356,382 | Form 4 |
| 1 February 2026 | Twomey Cormac J | EVP, Global Ops & Delivery | Shares withheld for tax | −1,439 | $37.35 | 56,995 | Form 4 |
| 29 January 2026 | Caldwell Christopher A | President and CEO | Open-market purchase | +1,000 | $37.07 | 362,075 | Form 4 |
| 28 January 2026 | Fogarty Jane | EVP, Legal | Grant or award | +220 | — | 31,672 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Concentrix page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.